{"id":"W4409722550","doi":"10.1007/s40273-025-01488-x","title":"Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada","year":2025,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Alectinib; Medicine; Lung cancer; Quality of Life Research; Oncology; Chemotherapy; Health economics; Adjuvant chemotherapy; Internal medicine; Pharmacoeconomics; Cisplatin; Intensive care medicine; Public health; Cancer; Crizotinib; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000673582,0.000138086,0.0003146578,0.00008283369,0.00004021021,0.000005776393,0.00006021533,0.00002631021,0.00003795725],"category_scores_gemma":[0.00000570616,0.0001242752,0.0000390927,0.0001227139,0.0000170458,0.0000531025,0.00001215245,0.00008213956,2.309604e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002364677,"about_ca_system_score_gemma":0.00290916,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.329517,"about_ca_topic_score_gemma":0.3314595,"domain_scores_codex":[0.9992945,0.00002128102,0.0001943851,0.0002315909,0.00004762363,0.0002106606],"domain_scores_gemma":[0.9992893,0.0003006523,0.00009638818,0.0001078453,0.000143419,0.00006234956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01921431,0.0006070229,0.9544552,0.001035778,0.001418806,0.000005552725,0.0005184963,0.005295807,0.00110318,0.00002493035,0.001622889,0.01469802],"study_design_scores_gemma":[0.1306969,0.000749191,0.6509863,0.0008266201,0.001472197,4.927809e-7,0.0003219096,0.01045091,0.1999593,0.00001408532,0.004112773,0.000409416],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920625,0.0003758615,0.0002530657,0.0001569958,0.000544234,0.003108513,0.0005149217,0.000005964598,0.00297793],"genre_scores_gemma":[0.9981011,0.0001961177,0.0002119216,0.0003246839,0.00002661905,0.0008123192,0.000115033,0.00002290944,0.000189364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.303469,"threshold_uncertainty_score":0.6807396,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01368345378869803,"score_gpt":0.3488611628773168,"score_spread":0.3351777090886188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}